Article
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing
6 Feb 2019
Abstract excerpt
OBJECTIVE: To evaluate perceptions toward pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI) who are prescribed dual antiplatelet therapy (DAPT) and whether geographical differences in these perceptions exist. PARTICIPANTS AND METHODS: TAILOR-PCI is the largest genotype-based cardiovascular clinical trial randomizing participants to conventional DAPT or prospective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
